SK279652B6 - Farmaceuticky účinný produkt z tanacetum partheniu - Google Patents

Farmaceuticky účinný produkt z tanacetum partheniu Download PDF

Info

Publication number
SK279652B6
SK279652B6 SK46-93A SK4693A SK279652B6 SK 279652 B6 SK279652 B6 SK 279652B6 SK 4693 A SK4693 A SK 4693A SK 279652 B6 SK279652 B6 SK 279652B6
Authority
SK
Slovakia
Prior art keywords
extraction
carbon dioxide
tanacetum parthenium
active product
extract
Prior art date
Application number
SK46-93A
Other languages
English (en)
Slovak (sk)
Other versions
SK4693A3 (en
Inventor
Norbert Beuscher
Ingo Willigmann
Original Assignee
Schaper & Br�Mmer Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6450610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK279652(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schaper & Br�Mmer Gmbh & Co. Kg filed Critical Schaper & Br�Mmer Gmbh & Co. Kg
Publication of SK4693A3 publication Critical patent/SK4693A3/sk
Publication of SK279652B6 publication Critical patent/SK279652B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
SK46-93A 1992-01-31 1993-01-29 Farmaceuticky účinný produkt z tanacetum partheniu SK279652B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4202657A DE4202657C2 (de) 1992-01-31 1992-01-31 Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel

Publications (2)

Publication Number Publication Date
SK4693A3 SK4693A3 (en) 1993-09-09
SK279652B6 true SK279652B6 (sk) 1999-02-11

Family

ID=6450610

Family Applications (1)

Application Number Title Priority Date Filing Date
SK46-93A SK279652B6 (sk) 1992-01-31 1993-01-29 Farmaceuticky účinný produkt z tanacetum partheniu

Country Status (19)

Country Link
US (1) US5466451A (ja)
EP (1) EP0553658B2 (ja)
JP (1) JP3611869B2 (ja)
CN (1) CN1074927C (ja)
AT (1) ATE150314T1 (ja)
BR (1) BR9300361A (ja)
CA (1) CA2088289C (ja)
CZ (1) CZ286486B6 (ja)
DE (2) DE4202657C2 (ja)
DK (1) DK0553658T4 (ja)
EG (1) EG20104A (ja)
ES (1) ES2099296T5 (ja)
GR (1) GR3023202T3 (ja)
HU (1) HUT64232A (ja)
MX (1) MX9300265A (ja)
PL (1) PL171097B1 (ja)
RU (1) RU2104017C1 (ja)
SK (1) SK279652B6 (ja)
UA (1) UA26917C2 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695931B1 (fr) * 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
WO1999033463A1 (en) * 1997-12-23 1999-07-08 Moser, René SESQUITERPENE LACTONES SPECIFICALLY INHIBIT ACTIVATION OF NF-λB BY PREVENTING THE DEGRADATION OF IλB-α AND IλB-$g(b)
DE19800330C2 (de) * 1998-01-07 2002-09-26 Delta 9 Pharma Gmbh Pharmazeutisch wirksamer CO¶2¶-Extrakt aus Tanacetum parthenium
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
GB2340120B (en) * 1998-08-01 2003-06-18 Essential Nutrition Ltd Nettle extract containing phytosterols
DE19844836A1 (de) 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
IT1312342B1 (it) * 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
CN1882354B (zh) * 2003-09-12 2012-07-04 捷通国际有限公司 细胞因子调节剂及相关用法
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
DE102004037002B4 (de) * 2004-07-30 2006-06-14 Chemieanlagenbau Chemnitz Gmbh Verfahren zur Herstellung von Dimethylaminoarglabin-Hydrochlorid
US20060222722A1 (en) * 2005-03-30 2006-10-05 Roberts Stephen C Sublingual methods of treatment to alleviate or prevent arthritis
US8409637B2 (en) * 2007-06-21 2013-04-02 Puramed Bioscience Inc. Compositions and methods for treating and preventing migrainous headaches and associated symptoms
CN103524520B (zh) * 2013-09-25 2015-12-09 中国人民解放军第四军医大学 一种从植物原料中提取小白菊内酯的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119454A1 (de) * 1981-05-15 1982-12-09 Haarmann & Reimer Gmbh, 3450 Holzminden Verfahren zur herstellung von konzentrierten extrakten aus frischen pflanzen oder teilen davon, insbesondere frischen kuechenkraeutern
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
GB8428747D0 (en) * 1984-11-14 1984-12-27 Hancock K A Products for treatment of human body
FI73962C (fi) * 1985-03-01 1987-12-10 Yhtyneet Paperitehtaat Oy Foerfarande foer framstaellning av vanillin.
FR2629735B1 (fr) * 1988-04-11 1991-03-22 Agronomique Inst Nat Rech Procede d'extraction au dioxyde de carbone supercritique de composes volatils, et composes obtenus
US4996317A (en) * 1988-08-05 1991-02-26 Kraft General Foods, Inc. Caffeine recovery from supercritical carbon dioxide
US5196575A (en) * 1992-02-19 1993-03-23 Hoechst Celanese Corp. Supercritical separation of isomers of functional organic compounds at moderate conditions

Also Published As

Publication number Publication date
ES2099296T3 (es) 1997-05-16
EP0553658A2 (de) 1993-08-04
HUT64232A (en) 1993-12-28
UA26917C2 (uk) 1999-12-29
EP0553658B2 (de) 2007-02-14
ES2099296T5 (es) 2007-10-16
DE59305824D1 (de) 1997-04-24
ATE150314T1 (de) 1997-04-15
BR9300361A (pt) 1993-08-24
CZ286486B6 (en) 2000-04-12
US5466451A (en) 1995-11-14
DK0553658T4 (da) 2007-03-19
EP0553658B1 (de) 1997-03-19
CA2088289A1 (en) 1993-08-01
EP0553658A3 (ja) 1994-02-16
PL297473A1 (en) 1993-08-09
DE4202657C2 (de) 1995-10-12
JP3611869B2 (ja) 2005-01-19
DK0553658T3 (da) 1997-04-07
HU9300069D0 (en) 1993-04-28
CA2088289C (en) 2002-11-12
MX9300265A (es) 1993-11-01
RU2104017C1 (ru) 1998-02-10
DE4202657A1 (de) 1993-08-05
CZ8293A3 (en) 1993-12-15
EG20104A (en) 1997-07-31
GR3023202T3 (en) 1997-07-30
SK4693A3 (en) 1993-09-09
CN1074615A (zh) 1993-07-28
JPH0656683A (ja) 1994-03-01
PL171097B1 (pl) 1997-03-28
CN1074927C (zh) 2001-11-21

Similar Documents

Publication Publication Date Title
SK279652B6 (sk) Farmaceuticky účinný produkt z tanacetum partheniu
Koumaglo et al. Effects of three compounds extracted from Morinda lucida on Plasmodium falciparum
AU678104B2 (en) Solvent extraction process
KR20000076328A (ko) 히퍼리컴 퍼포라툼 엘의 안정 추출물, 그의 제조방법과 약학조성물
US4549990A (en) Manufacture of non-saponifiable compounds from natural substances and the resulting products
EP1140885A1 (en) Method for high yield extraction of paclitaxel from paclitaxel-containing material
US3150050A (en) Extraction of essential perfume fragrance components with fluorinated hydrocarbons
EP1156995A1 (en) Process for extraction of an organic salt from plants, the salt, and other similar salts
NZ514957A (en) Solvent extraction process for extraction of flavour or fragrance compositions from plant materials
AU2001285374B2 (en) Method of providing an essential oil extract of capsicum, and the extract
EP3466936A1 (en) Processes for extracting cynaropicrin from leaves of cynara cardunculus l.
US5763626A (en) Maltol recovery
Islam In vitro evaluation of thrombolytic and antioxidant scavenging activity of eichhornia crassipes
RU2238663C2 (ru) Способ получения биологически активного продукта из allium victorialis
US2396679A (en) Process for treating fat-soluble vitamin-bearing materials
JP3146677B2 (ja) 天然抗酸化物質の製造方法
RU2020944C1 (ru) Способ получения липидсодержащей фракции
US20020004079A1 (en) Process for the extraction of a compound by a fluorocarbon compound
MXPA96005220A (en) Recovery of evil
PL172705B1 (pl) Sposób otrzymywania preparatów fotouczulających

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100129